reverse dot blot assay (rdb) kit  (HybriBio Limited)

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: Analysis of the related factors of atypical squamous cells of undetermined significance (ASC-US) in cervical cytology of post-menopausal women

doi: 10.3389/fcimb.2023.1123260

Figure Lengend Snippet: Histopathologic results for pre- and post-menopausal women with ASC-US according to HPV genotyping.

Article Snippet: The HR-HPV genotypes (16,18,31,33,35,39,45,51,52,53,56,58,59,66,68,73,82 and 83) were detected using a polymerase chain reaction-reverse dot blot (PCR-RDB) HPV genotyping kit (YaNeng Biosciences, Shenzhen, China).

Techniques:

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: Analysis of the related factors of atypical squamous cells of undetermined significance (ASC-US) in cervical cytology of post-menopausal women

doi: 10.3389/fcimb.2023.1123260

Figure Lengend Snippet: Histopathologic results for pre- and post-menopausal women with ASC-US according to single HPV genotyping.

Article Snippet: The HR-HPV genotypes (16,18,31,33,35,39,45,51,52,53,56,58,59,66,68,73,82 and 83) were detected using a polymerase chain reaction-reverse dot blot (PCR-RDB) HPV genotyping kit (YaNeng Biosciences, Shenzhen, China).

Techniques:

Journal: Cancer Management and Research

Article Title: Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China

doi: 10.2147/CMAR.S237490

Figure Lengend Snippet: The HR-HPV distribution in CIN 2+ and CIN 3+. ( A ) HR-HPV distribution in pre-operation of CIN 2+; ( B ) HR-HPV distribution in pre-operation of CIN 3+; ( C ) HR-HPV distribution in post-operation of CIN 2+; ( D ) HR-HPV distribution in post-operation of CIN 3+. CIN 2+ included CIN 2, CIN 3, and cervical cancer; CIN 3+ included CIN 3 and cervical cancer. Abbreviations: CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; HR-HPV, high-risk human papillomavirus.

Article Snippet: In our previous study, the PCR-reverse dot blot (PCR-RDB) Yaneng ® Human Papillomavirus Genotyping Kit (Yaneng Biotech, Shenzhen, China), which detects 18 HR-HPV types (HPV-16, −18, −31, −33, −35, −39, −45, −51, −52, −53, −56, 58, −59, −66, −68, −73, −82, and −83) and 5 low-risk (LR)-HPV types (HPV-6, −11, −42, −43, and −81), was evaluated in a hospital-based population and showed a reliable and sensitive clinical reference for cervical screening.

Techniques:

Journal: Cancer Management and Research

Article Title: Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China

doi: 10.2147/CMAR.S237490

Figure Lengend Snippet: The cumulative risk of residual or recurrence of CIN 2+ for postoperative patients in four4 years. ( A ) Cumulative CIN 2+ progression risk during 4 years follow-up in different age groups; ( B ) Cumulative CIN 2+ progression risk during 4 years follow-up in different HR-HPV infection numbers; ( C ) Cumulative CIN 2+ progression risk during 4 years follow-up in different margin status; ( D ) Cumulative CIN 2+ progression risk during 4 years follow-up in different gland invasive status; ( E ) Cumulative CIN 2+ progression risk during 4 years follow-up in different cytology result; ( F ) Cumulative CIN 2+ progression risk during 4 years follow-up in different pathology result; ( G ) Cumulative CIN 2+ progression risk during 4 years follow-up in different HR-HPV infection status; ( H ) Cumulative CIN 2+ progression risk during 4 years follow-up in different HR-HPV genotypes. CIN 2+ included CIN 2, CIN 3, and cervical cancer. Abbreviations: HPV, human papillomavirus; TP-HPV, type-specific HPV infection; CIN, cervical intraepithelial neoplasia; HR-HPV, high-risk human papillomavirus.

Article Snippet: In our previous study, the PCR-reverse dot blot (PCR-RDB) Yaneng ® Human Papillomavirus Genotyping Kit (Yaneng Biotech, Shenzhen, China), which detects 18 HR-HPV types (HPV-16, −18, −31, −33, −35, −39, −45, −51, −52, −53, −56, 58, −59, −66, −68, −73, −82, and −83) and 5 low-risk (LR)-HPV types (HPV-6, −11, −42, −43, and −81), was evaluated in a hospital-based population and showed a reliable and sensitive clinical reference for cervical screening.

Techniques: Infection

Journal: Journal of Gynecologic Oncology

Article Title: Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study

doi: 10.3802/jgo.2017.28.e50

Figure Lengend Snippet: Prevalence of different HPV genotype infections. (A) HPV-16 is most prevalent genotype in HPV-positive women. (B) The HR-HPV infection rate showed a bimodal trend, and the rates of different age groups were statistically significant (χ 2 =272.740; p<0.001). Top 5 most frequent HPV genotypes in (C) NILM patients; (D) LSIL (CIN1) patients; (E) HSIL patients (CIN2 and CIN3); and (F) cervical cancer. Orange bar in (C-F) is the cumulative cases of HPV genotypes. CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; HR-HPV, high-risk human papillomavirus; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; NILM, negative for intraepithelial lesion or malignancy.

Article Snippet: In this study, we evaluated the PCR-reverse dot blot (PCR-RDB) Yaneng ® Human Papillomavirus Genotyping kit (Yaneng Biotech, Shenzhen, China) for the detection of 23 types, 18 HR, and 5 LR-HPV types.

Techniques: Infection

Journal: Journal of Gynecologic Oncology

Article Title: Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study

doi: 10.3802/jgo.2017.28.e50

Figure Lengend Snippet: Age-related distribution of HPV infection. Top 5 most frequent HPV genotypes in different age groups of (A) NILM patients; (B) LSIL (CIN1) patients; (C) HSIL patients (CIN2 and CIN3); and (D) cervical cancer. CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; NILM, negative for intraepithelial lesion or malignancy.

Article Snippet: In this study, we evaluated the PCR-reverse dot blot (PCR-RDB) Yaneng ® Human Papillomavirus Genotyping kit (Yaneng Biotech, Shenzhen, China) for the detection of 23 types, 18 HR, and 5 LR-HPV types.

Techniques: Infection

Journal: Journal of Gynecologic Oncology

Article Title: Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study

doi: 10.3802/jgo.2017.28.e50

Figure Lengend Snippet: Cumulative occurred risk of HR-HPV genotype for cervical lesions. Cumulative occurred risk of each HPV genotype: in patients with (A) a pathologically diagnosed CIN1; (B) CIN2; (C) CIN3; and (D) invasive cervical cancer. Orange bar represents statistically significant (p<0.05) green bar represents not statistically significant (p>0.05). CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; HR-HPV, high-risk human papillomavirus.

Article Snippet: In this study, we evaluated the PCR-reverse dot blot (PCR-RDB) Yaneng ® Human Papillomavirus Genotyping kit (Yaneng Biotech, Shenzhen, China) for the detection of 23 types, 18 HR, and 5 LR-HPV types.

Techniques: